Targeted proteomics in biomarker validation: detection and quantification of proteins using a multi-dimensional...

Area of Science:

• Biomarker Discovery
• Analytical Chemistry
• Mass Spectrometry

Background:

• Biomarkers are vital for drug discovery and development, but their validation is time-consuming.
• Current methods for biomarker validation using mass spectrometry (MS) have limitations, including non-generic detection and quantification.
• Analyzing complex biological fluids requires efficient strategies to achieve high analytical sensitivity.

Purpose of the Study:

• To present a proof-of-principle for an accelerated, multi-dimensional MS strategy for initial biomarker candidate validation.
• To develop a generally applicable, sensitive, and quantitative method for biomarker assessment.
• To overcome limitations of existing MS-based validation approaches.

Main Methods:

• A multi-dimensional strategy combining electrophoretic and chromatographic separation on the peptide level.
• Mass spectrometry (MS) quantification utilizing isotopically labeled synthetic peptides as internal standards.
• A workflow incorporating up to four dimensions for enhanced analytical performance.

Main Results:

• The developed method achieves a low limit of detection (LOD) suitable for quantifying diagnostically relevant analytes in complex samples.
• The strategy demonstrates potential for sensitive and quantitative analysis.
• The approach is designed to be generally applicable across various biomarker candidates.

Conclusions:

• The presented multi-dimensional MS strategy offers a promising approach for accelerated initial biomarker validation.
• This method has the potential to significantly expedite the drug discovery and development pipeline.
• Further validation and development are expected to enhance its utility in biomarker research.